Report by
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Kilitch Healthcare India Limited Lubricant Eye Drops & Multi-Symptom Eye Drops - recalled due to insanitary conditions, USA
3 weeks ago
United States
Kilitch Healthcare India Limited is voluntarily recalling the eye drops products to the consumer level with all lots within expiry with expiration dates ranging from November, 2023 to September, 2025 for all the below mentioned products. These products are being recalled due to potential safety concerns after FDA investigators found insanitary conditions. These products were distributed nationwide to wholesalers, retailers, and via the product distributor, Velocity Pharma LLC. To date, Kilitch Healthcare India Limited has not received any reports of adverse events related to this recall.
Risk Statement: For those patients who use these products, there is a potential risk of eye infections or related harm. These products are intended to be sterile. Ophthalmic drug products pose a potentially heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses.
Affected products:
- Product: LUBRICATING TEARS EYE DROPS 15 ML. Product Information: Dextran 70- 0.1% w/v, Glycerin 0.2% w/v, Hypromellose 0.3% w/v. NDC NO: 0536-1282-94. Retailer / Label: Rugby.
- Product: Polyvinyl Alcohol 1.4% Lubricating Eye Drops 15 ml. Product Information: Polyvinyl alcohol Eye Drops 1.4% w/v. NDC NO: 0536-1325-94. Retailer / Label: Rugby.
- Product: High Performance Lubricant Eye Drops 15 ml (Single Pack). Product Information: Polyethylene glycol 400 0.4%, Propylene glycol 0.3% Eye Drops. NDC NO: 11673-522-15. Retailer / Label: Target.
- Product: High Performance Lubricant Eye Drops 15 ml (Twin Pack). Product Information: Polyethylene glycol 400 0.4%, Propylene glycol 0.3% Eye Drops. NDC NO: 11673-522-30. Retailer / Label: Target.
- Product: MULTI-ACTION RELIEF DROPS 15ML. Product Information: Polyvinyl alcohol 0.5% w/v, Povidone 0.6%w/v, Tetrahydrozoline 0.05% Eye Drops. NDC NO: 11822-2254-3. Retailer / Label: Rite Aid.
- Product: LUBRICATING GEL DROPS 10ML. Product Information: Polyethylene glycol 400 0.4%, Propylene glycol 0.3% Eye Drops. NDC NO: 11822-4540-3. Retailer / Label: Rite Aid.
- Product: LUBRICANT EYE DROPS 10ML (TWIN PACK). Product Information: Propylene glycol Eye Drops 0.6% w/v. NDC NO: 11822-4811-3. Retailer / Label: Rite Aid.
- Product: LUBRICANT GEL DROPS 15 ML. Product Information: Carboxymethylcellulose Sodium Eye Drops 1.0% W/V. NDC NO: 11822-9706-5. Retailer / Label: Rite Aid.
- Product: LUBRICANT EYE DROPS 15ML (TWIN PACK). Product Information: Carboxymethylcellulose Sodium Eye Drops 0.5% W/V. NDC NO: 11822-9707-5. Retailer / Label: Rite Aid.
- Product: Eye Irritation Relief 15 ml. Product Information: Polyvinyl alcohol 0.5% w/v, Povidone 0.6%w/v, Tetrahydrozoline 0.05% Eye Drops. NDC NO: 70000-0087-1. Retailer / Label: Leader.
- Product: Dry Eye Relief 10 ml. Product Information: Polyethylene glycol 400 0.4%, Propylene glycol 0.3% Eye Drops. NDC NO: 70000-0088-1. Retailer / Label: Leader.
- Product: Dry Eye Relief 15 ml. Product Information: Carboxymethylcellulose Sodium Eye Drops 1.0% W/V. NDC NO: 70000-0089-1. Retailer / Label: Leader.
- Product: Lubricant Eye Drops 15 ML (Single Pack). Product Information: Carboxymethylcellulose Sodium Eye Drops 0.5% W/V. NDC NO: 70000-0090-1. Retailer / Label: Leader.
- Product: Lubricant Eye Drops 15 ML (Twin Pack). Product Information: Carboxymethylcellulose Sodium Eye Drops 0.5% W/V. NDC NO: 70000-0090-2. Retailer / Label: Leader.
- Product: Lubricant Eye Drops 10 ml. Product Information: Propylene glycol Eye Drops 0.6% w/v. NDC NO: 70000-0587-1. Retailer / Label: Leader.
- Product: LUBRICANT EYE DROP 10ML (TRIPLE PACK). Product Information: Propylene glycol Eye Drops 0.6% w/v. NDC NO: 76168-502-30. Retailer / Label: Velocity.
- Product: Lubricant Eye Drops 15 ML (Single Pack). Product Information: Carboxymethylcellulose Sodium Eye Drops 0.5% W/V. NDC NO: 76168-702-15. Retailer / Label: CVS.
- Product: Lubricant Eye Drops 15 ML (Twin Pack). Product Information: Carboxymethylcellulose Sodium Eye Drops 0.5% W/V. NDC NO: 76168-702-30. Retailer / Label: CVS.
- Product: Lubricant Gel Drops 15 ml (Single Pack). Product Information: Carboxymethylcellulose Sodium Eye Drops 1.0% W/V. NDC NO: 76168-704-15. Retailer / Label: CVS.
- Product: Lubricant Gel Drops 15 ml (Twin Pack). Product Information: Carboxymethylcellulose Sodium Eye Drops 1.0% W/V. NDC NO: 76168-704-30. Retailer / Label: CVS.
- Product: Multi Action Relief Drops 15 ml. Product Information: Polyvinyl alcohol 0.5% w/v, Povidone 0.6%w/v, Tetrahydrozoline 0.05% Eye Drops. NDC NO: 76168-706-15. Retailer / Label: CVS.
- Product: MILD MODERATE LUBRICATING EYE DROPS 15ML. Product Information: Polyethylene glycol 400 0.4% w/v. NDC NO: 76168-711-15. Retailer / Label: CVS.
- Product: Lubricant Gel Drops 10 ml. Product Information: Polyethylene glycol 400 0.4%, Propylene glycol 0.3% Eye Drops. NDC NO: 76168-712-10. Retailer / Label: CVS.
- Product: Lubricant Eye Drops 10 ml (Single Pack). Product Information: Propylene glycol Eye Drops 0.6% w/v. NDC NO: 76168-714-10. Retailer / Label: CVS.
- Product: Lubricant Eye Drops 10 ml (Twin Pack). Product Information: Propylene glycol Eye Drops 0.6% w/v. NDC NO: 76168-714-20. Retailer / Label: CVS.
- Product: DRY EYE RELIEF 15 ML (TWIN PACK). Product Information: Carboxymethylcellulose Sodium Eye Drops 0.5% W/V. NDC NO: 76168-800-30. Retailer / Label: Target.
- Product: EQUATE HYDRATION PF LUBRICANT EYE DROPS 10ML. Product Information: Polyethylene glycol 400 0.4%, Propylene glycol 0.3% Eye Drops. NDC NO: 79903-168-01. Retailer / Label: Walmart.
Consumers, distributors, and retailers that have any product that is being recalled should cease distribution of the product. Consumers should stop using the recalled eye drops and may return any of the products to the place of purchase.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Kilitch Healthcare India Limited
Brand name: Multiple brands
Product recalled: Lubricant Eye Drops & Multi-Symptom Eye Drops
Reason of the recall: Device & Drug Safety Potential Safety Concerns
FDA Recall date: November 15, 2023
Source: fda.gov
Related Reports
Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump. The Correction is due to the potential for an incomplete infusion following one or more downstream occlusion alarms. Baxter notified impacted customers in October and is developing... See More a software upgrade to resolve the issue. There have been no reports of serious injury associated with this issue to date. This infusion pump was distributed in the United States.
Baxter has identified that after one or more downstream occlusion alarms occur on the Novum IQ syringe pump, the pump may display an “Infusion Complete” alarm despite fluid remaining in the syringe. This could lead to an underdose and/or interruption of therapy. The difference between the remaining volume to be infused displayed on the pump and the volume left in the syringe is dependent on the number of occlusion alarms encountered during an infusion and the size of the syringe being used.
If a patient does not receive the intended dose of a prescribed medication, serious or critical adverse health consequences may occur. Potential health consequences are dependent on multiple patient-specific factors (such as disease state as well as age and weight of the patient involved, and the care area where they are treated), occlusion pressure settings, the number of occlusions that occurred, the size of the syringe used, and the therapy being delivered.
This Urgent Medical Device Correction applies to Novum IQ syringe infusion pump with product code 40800BAXUS. Baxter has contacted affected customers and is developing a software update to resolve the issue. Until the software update is available, customers can continue to use Novum IQ syringe infusion pumps with the following reinforced guidance provided by Baxter:
- As stated in the pump’s Operator’s Manual, users should choose the smallest compatible syringe size necessary to deliver the fluid or medication.
- Prior to beginning an infusion, users should ensure the downstream occlusion pressure setting is appropriate for the clinical scenario. Consistent with standard clinical practice, users should always check for clamped lines and other sources of downstream occlusion prior to and during therapy. Pressure setting selection guidelines and instructions for downstream occlusion resolution can be found in section 8.8 of the Operator’s Manual.
- Per standard clinical practice, users should continue to monitor the “Volume to be Infused” and the volume delivered while therapy is in progress. This is especially true after a downstream occlusion alarm has occurred. Users should also take note of the initial volume and compare it to the final volume in the syringe. If the total dose is not delivered upon the “Infusion Complete” alarm, users should reprogram the pump and deliver the remaining volume as necessary.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Baxter International, Inc.
Brand name: Baxter
Product recalled: Novum IQ syringe infusion pump.
Reason of the recall: Potential for an incomplete infusion following one or more downstream occlusion alarms.
FDA Recall date: November 30, 2023
Source: fda.gov See Less
Meta Herbal is voluntarily recalling 500 blister packs of Magnum XXL 9800 2000 mg per capsule, to the consumer level. The products have been found to be tainted with Sildenafil. Products containing sildenafil cannot be marketed as dietary supplements. Magnum XXL 9800 capsules is an unapproved new... See More drug for which safety and efficacy have not been established and, therefore, subject to recall. The product was distributed and sold online on Amazon under the ASINs: B07P7ZH797, B07P94J3ZT, B07P6VK6N3, B076HNPZZZ. To date, Meta Herbal has not received any reports of adverse events related to this recall.
Sildenafil is an ingredient known as a Phosphodiesterase Inhibitor (PDE-5) found in FDA-approved products for the treatment of male erectile dysfunction.
Risk Statement: Consumption of products with undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life-threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.
The tainted product is marketed as a dietary supplement for male sexual enhancement and is packaged in blister packs of one pill, with a UPC 645759993007 exp 1/2025. Each blister pack is sold individually and holds one capsule.
Meta Herbal is notifying its customers via Amazon and is arranging for refunds. All blister packs of Magnum XXL 9800 are affected by this recall. Consumers who have the recalled product should stop using it and contact Meta Herbal for return/refund instructions.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Meta Herbal
Brand name: Magnum
Product recalled: Magnum Male Sexual Enhancement XXL 9800 capsule
Reason of the recall: Undeclared Sildenafil
FDA Recall date: November 29, 2023
Source: fda.gov See Less
Novartis Sandimmune Oral Solution - recalled due to due to crystallization formation, USA
1 week ago
Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. The issue was identified... See More during an investigation of crystallization in a different lot of Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL. No other Sandimmune formulations are impacted. They were distributed nationwide to wholesalers across the US, beginning in January 2022 and September 2022, respectively. Novartis has not received any reports of adverse events related to this recall, to date.
Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL, packaged in 50 mL bottles, is indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. The drug may also be used in the treatment of chronic rejection in patients previously treated with other immunosuppressive agents.
Risk Statement: Crystallization of cyclosporine in Sandimmune Oral Solution is likely to result in non-uniform distribution of the cyclosporine in the product, resulting in under-dosing or over-dosing. There is a reasonable probability that under-dosing may result in lower exposures and decrease in efficacy which could ultimately lead to graft rejection and graft loss in transplant patients. Furthermore, over-dosage may manifest itself as cyclosporine toxicity in the long term if overexposure continues.
The affected lot numbers and expiration dates are:
- FX001500 (expiration date 09/2024)
- FX001582 (expiration date 09/2024) NDC 0078-0110-22.
These lots were only distributed in the US.
Novartis is notifying its distributors via a recall notification letter and is arranging for the return of the recalled lot from distributors, retailers, and consumers. Additionally, Novartis is notifying healthcare providers who have prescribed this product to contact their patients. Consumers who have bottles from the recalled lot of Sandimmune Oral Solution (cyclosporine oral solution, USP), 100mg/mL, should contact their healthcare provider.
In the event that a patient experiences an adverse reaction or quality problem involving this product, they should immediately contact their healthcare provider.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Novartis Pharmaceuticals Corporation
Brand name: Novartis
Product recalled: Sandimmune (cyclosporine oral solution, USP) Oral Solution 100 mg/mL
Reason for the recall: Due to crystallization formation
FDA Recall date: November 27, 2023
Source: fda.gov See Less
Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lots of the... See More product contained elevated levels of benzene. The affected lots were distributed nationwide in the United States through a limited number of retailers and online. To date, the Company has not received any serious adverse events related to this recall.
Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it potentially can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life-threatening. Insight is recalling these products out of an abundance of caution. Benzene is ubiquitous in the environment. Humans around the world have daily exposure to it indoors and outdoors from multiple sources.
TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder is packaged in green and white aerosol cans with Lot codes located on the bottom of the can.
Samples of the recalled lots below have been found to contain trace levels of Benzene related to the propellant that sprays the product out of the can. Benzene is not an ingredient in any Ting products.
Affected products:
- Product: TING 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder, NDC: 63736-532-05, Lot Code: 0H88645, Expiration: 07/24, Package Size: 4.5 oz/128 g
- Product: TING 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder, NDC: 63736-532-05, Lot Code: 0B88345, Expiration: 02/24, Package Size: 4.5 oz/128 g
Insight has notified retailers via overnight mail to remove any remaining recalled product from shelves and follow the instructions provided in the Drug Recall Notification. The company will also offer reimbursement for consumers who have purchased TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray marked with one of the lot codes.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Insight Pharmaceuticals
Brand name: TING®
Product recalled: 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal SprayPowder
Reason for the recall: Presence of benzene
FDA Recall date: November 24, 2023
Source: fda.gov See Less
Bayer Vitrakvi (larotrectinib) Oral Solution - recalled due to microbial contamination, USA
2 weeks ago
Bayer is voluntarily recalling one lot of Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles to the consumer/user level. The product is being recalled due to microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing. It was distributed to wholesale distributors and... See More specialty pharmacies nationwide between January 3, 2023, and February 13, 2023. To date, Bayer has not received any adverse events related to this recall.
Risk Statement: Vitrakvi® is indicated for the treatment of solid tumors that are NTRK gene fusion positive, it is expected that patients on Vitrakvi® may be immunocompromised. Although there is little data in the literature on human pathology caused by Penicillium brevicompactum, there are cases of invasive disease caused by similar Penicillium species, particularly in patients with underlying immunosuppression. Therefore, there is a reasonable probability that ingestion of Penicillium brevicompactum in patients on Vitrakvi® with underlying immunosuppression may result in invasive fungal infections of the blood or pneumonia that can be life-threatening.
The impacted lot of Vitrakvi® is packaged in a 100mL glass bottle with NDC# 50419-392-01 and is identified with Lot# 2114228 and an expiration date of February 29, 2024. Product bottle and carton label images and information on the lot number that falls under this recall is attached
Bayer notified all distributors and pharmacies of this recall on November 8, 2023. Bayer has engaged Qualanex to manage the recall of the product down to the consumer level. Qualanex has notified Vitrakvi® distributors via a recall notification letter and will arrange for the return of the recalled lot from distributors, specialty pharmacies, and consumers.
Consumers who have the recalled Vitrakvi® product should immediately stop use of this particular lot of product and contact their physician or healthcare provider if they have any questions, concerns or have experienced any problems related to Vitrakvi® Oral Solution 20 mg/mL.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: Bayer
Brand name: Bayer
Product recalled: Vitrakvi® (larotrectinib) Oral Solution 20 mg/mL in 100mL glass bottles
Reason of the recall: Microbial contamination identified as Penicillium brevicompactum
FDA Recall date: November 21, 2023
Source: fda.gov See Less
FRC, 192-01 Northern Blvd, Flushing, NY, USA
5 hours ago
Ordered 3 space heaters ... they were delivered in crushed old boxes and don't work calling credit card company for refund See Less
Boil Water Advisory Lifted, Glendale, OR, USA
6 hours ago
The Boil Water advisory issued for customers in the city of Glendale, Oregon has been lifted, according to the City Manager.
Source: kezi.com
Published: 2023-12-06 See Less
Boil Water Advisory, Cove Road, Weirton, WV, USA
6 hours ago
A boil water order has been issued for customers in Weirton following work on a water line along Cove Road. The order is in effect for the 400 block of Cove Road, as well as Overbrook Drive, Garden Way and Spring Street, as well as any other... See More water customers in the area who lost pressure.
Source: weirtondailytimes.com
Published: 2023-12-06 See Less
Power Outage, Riverdale, CA, USA
6 hours ago
A power outage has been reported in Riverdale today December 6th at 11:25 a.m. Customers affected: 147. Cause of the outage: Patrolling.The estimated restoration time is today, December 6 at 5:45 p.m.
Outage link: pgealerts.alerts.pge.com
Source: lostcoastoutpost.com
Published: 2023-12-06 See Less
An electrical service disruption was reported in sections of Deep Gap on Wednesday morning. According to Blue Ridge Energy's outage map, hundreds of customers were without power due to high winds. Those outages began at 11:55 am and ended at 1:59 pm. The most affected areas were:... See More Caldwell county with 251 customers affected, Watauga County 413 with customers affected. Power has been restored to the area.
Outage link: bremco.maps.sienatech.com
Source: wataugaonline.com
Published: 2023-12-06 See Less
Recent Interesting Reports
KinderMed OTC Pain and Fever Reliever for Infants and Kids - recalled due to Acetaminophen Instability, USA
2 weeks ago
KinderFarms, LLC is voluntarily recalling all lots of KinderMed Infants’ Pain & Fever (oral suspension) and KinderMed Kids’ Pain & Fever (oral suspension) to the retail and consumer level. These products are being voluntarily recalled due to acetaminophen instability. These products are available nationwide in drug/pharmacy, supermarkets,... See More direct delivery and national retailers, and online through major ecommerce sites. The company has not received any reports of serious adverse events from either of these products to date.
The two products were manufactured and packaged for KinderFarms by a major, U.S.-based OTC pharmaceutical manufacturer with over 30 years of experience. Ongoing testing of sample batches indicated some product lots were no longer in specification and may pose a health risk. Acetaminophen is the active ingredient in many pain-relieving medicines. As a result of the potential health risk with acetaminophen being outside of specification, the product may cause acute adverse health effects, including abdominal pain, nausea, vomiting or jaundice at higher doses.
This voluntary recall encompasses all products currently available on shelf of these two SKUs only. The impacted product being voluntarily recalled is all lots of:
- KinderMed Infants’ Pain & Fever (2 fluid ounces/59 mL), (Acetaminophen - 160 mg per 5 mL), Oral Suspension. UPC: 850001805698
- KinderMed Kids’ Pain & Fever (4 fluid ounces/118 mL), (Acetaminophen - 160 mg per 5 mL), Oral Suspension. UPC: 850001805728
Consumers who purchased either of these two products should stop using them and may return the product to the place of purchase for a full refund.
In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.
Company name: KinderFarms, LLC
Brand name: KinderMed
Product recalled: OTC Pain and Fever Reliever for Infants and Kids
Reason of the recall: Due to Acetaminophen Instability
FDA Recall date: November 17, 2023
Source: fda.gov See Less
Received a package from GRA That is a Ring. Came from Ney York. I did not order this item See Less
I received a package from HBK Tech LLC,I didnt order. A NFL jersey and some stup*d stickers. See Less
I ordered a vest and I did not receive the item I ordered. See Less
Package I didn’t order, Millville, NJ, USA
2 days ago
White pack with wadded up trash from best deals llc 173 st rfresh meadows ny. See Less
I received 2 items i have no idea what they are the look like click lipsticks but nothing is in them says it came from shipping ctr 609 cattle chute ct celina tx See Less
Online SCAM, Gaspé, QC, Canada
2 weeks ago
I ordered red winter boots and received the khaki color. Moreover, they are far from being good at minus 35, as she mentions. I am trying every way to contact me to return them and get a refund, but it is not possible. I don't know what... See More to do anymore. IT'S A PURE SCAM See Less
I suspect this is a brushing scam, based on similar reports, possibly related to a purchase from what turned out to be a fake Balsam Hill Christmas tree clearance site. Just out of curiosity, anyone who got a moissanite ring, does yours also use the report number... See More 21889****? I’m guessing they all do. See Less
Scammed, ACQUAINT- topmallsales
1 day ago
Ordered a Stanley tumbler on 11/25/23. S opposed lt shipped 11/28/23-tracking received doesn’t work. Pretty sure I’ve be scammed. Advertised on IG. See Less
Unordered Package, Murphy, NC, USA
2 days ago
I have ordered 2 Cosmos heaters and have yet to receive them. Is this a scam? Tracking #926129033961070143**** See Less
